None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women aged 45-85 years old 2) Patients diagnosed with [G20] Parkinson's disease 3) Those who volunteered to participate and signed the consent form 4) (For those 75 and older) Those with a K-MMSE-2 score of 24 or higher
Exclusion criteria
Exclusion criteria: 1) Patients with dementia, Huntington's disease, hydrocephalus, brain tumors, cardiovascular disorders (myocardial infarction, angina pectoris, etc.), cerebrovascular diseases (stroke, cerebral hemorrhage, etc.) in the acute and subacute stages, pregnant women 2) Patients with implantable electronic devices such as pacemakers 3) Other individuals who are deemed unsuitable for participation in this clinical study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate variability (HRV) measurements | — |
Secondary
| Measure | Time frame |
|---|---|
| Electroencephalography (EEG) measurements | — |
Countries
Korea, Republic of
Contacts
Daejeon Korean Medicine Hospital of Daejeon University